BackCeryvyn Therapeutics Overview

Ceryvyn Therapeutics Other Current Liabilities

Track Ceryvyn Therapeutics's other current liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$0.00
↓ 100.00% YoYΔ $-61.68M vs prior year quarter

Peer trimmed avg / median

Loading

Ceryvyn Therapeutics Other Current Liabilities History

Loading

Ceryvyn Therapeutics vs. peers: Other Current Liabilities Comparison

Loading

Ceryvyn Therapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ceryvyn Therapeutics (OPT.AX) FAQ

The latest other current liabilities for OPT.AX is $0 as of December 2025. That compares with $62M in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Ceryvyn Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPT.AX's other current liabilities moved from $62M to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ceryvyn Therapeutics's operating scale or balance-sheet position.

A other current liabilities figure of $0 for OPT.AX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OPT.AX's other current liabilities ($0), review year-over-year change from $62M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ceryvyn Therapeutics's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.

Questions & Answers